Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Therapeutic Advances in the Management of Patients with Gastrointestinal Cancer

Program Overview

This CME post-conference review and analysis will highlight therapeutic advances in the management of patients with gastrointestinal cancer, including data presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022. The expert faculty will analyze the latest therapeutic advances for the treatment and management of gastrointestinal (GI) cancer as presented at ASCO GI 2022. They ...
View Course
Welcome to this AcademicCME Nephrology Network Program. These “quick hitting” programs focus on a visual comparison between two important studies in a single issue of importance to those clinicians who care for the kidneys and the patients in which those kidneys live. This Nephrology Network program is accredited for up to 1.5hr CME (physicians) and CE (nurses, NPs, PAs, pharmacists) ...
View Course
Join Dr. Stephen Krieger (@SKriegerMD), a Professor Neurology at the Corinne Goldsmith Dickinson Center for MS at Mount Sinai, in a unique CE/CME-accredited video. Dr. Krieger sits down for an honest 1:1 conversation with one of his first patients, Kate Milliken, with whom he has had a doctor-patient relationship for 15 years. They discuss how considering the patient’s perspective is ...
View Course
Applying JAK Inhibitor Therapeutics to Improve Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis

Program Overview

This CME/CE program is derived from content presented at the Maui Derm for Dermatologists 2022 Annual Meeting. The expert faculty, led by Lawrence Eichenfield, MD, will highlight the use of Janus kinases (JAK) inhibitor therapeutics to improve outcomes in patients with atopic dermatitis. The faculty will begin with an overview of current clinical trial data, including new and ...
View Course

Upcoming Events

Advanced Curriculum for Multiple Sclerosis 2024

February 27th, 2024

ACTRIMS Forum 2024

February 29th – March 2nd, 2024

Georgia Neurological Society Annual Meeting

March 22nd – 23rd, 2024

San Francisco Neurological Society Annual Meeting

March 22nd – 24th, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *